The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.

Severe sepsis, defined as sepsis with acute organ dysfunction, is associated with high morbidity and mortality rates. The development of novel therapies for sepsis is critically dependent on an understanding of the basic mechanisms of the disease. The pathophysiology of severe sepsis involves a highly complex, integrated response that includes the activation of a number of cell types, inflammatory mediators, and the hemostatic system. Central to this process is an alteration of endothelial cell function. The goals of this article are to (1) provide an overview of sepsis and its complications, (2) discuss the role of the endothelium in orchestrating the host response in sepsis, and (3) emphasize the potential value of the endothelium as a target for sepsis therapy.

[1]  C. Hack,et al.  Time course of cytokine levels in sepsis , 1995, Intensive Care Medicine.

[2]  Abraham,et al.  Adjunctive therapy in sepsis : a critical analysis of the clinical trial programme , 2005 .

[3]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[4]  Michael Bustin,et al.  Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. , 2003, Blood.

[5]  José A Fernández,et al.  Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective , 2003, Nature Medicine.

[6]  W. Aird,et al.  Thrombin Stimulation of Vascular Adhesion Molecule-1 in Endothelial Cells Is Mediated by Protein Kinase C (PKC)-δ-NF-κB and PKC-ζ-GATA Signaling Pathways* , 2003, The Journal of Biological Chemistry.

[7]  W. Aird,et al.  Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. , 2003, The Journal of biological chemistry.

[8]  Charles Natanson,et al.  Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. , 2002, American journal of respiratory and critical care medicine.

[9]  K. Isobe,et al.  Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. , 2002, The American journal of pathology.

[10]  E. Abraham,et al.  Does blocking cytokines in sepsis work? , 2002, American journal of respiratory and critical care medicine.

[11]  Yuji Saito,et al.  Fluid Shear Stress Attenuates Hydrogen Peroxide–Induced c-Jun NH2-Terminal Kinase Activation via a Glutathione Reductase–Mediated Mechanism , 2002, Circulation research.

[12]  John D Lambris,et al.  Protection of innate immunity by C5aR antagonist in septic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  F. Gruber,et al.  Protective role of phospholipid oxidation products in endotoxin-induced tissue damage , 2002, Nature.

[14]  C. Esmon New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins , 2002, The Journal of experimental medicine.

[15]  P. Hellings,et al.  The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways , 2002, The Journal of experimental medicine.

[16]  A. Malhotra,et al.  Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[17]  M. Hottiger,et al.  The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders , 2002, Cellular and Molecular Life Sciences CMLS.

[18]  D. Annane,et al.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.

[19]  B. Lämmle,et al.  C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction , 2002, Critical care medicine.

[20]  J. Hamilton,et al.  GM-CSF in inflammation and autoimmunity. , 2002, Trends in immunology.

[21]  M. Weller,et al.  Proteasome inhibition leads to NF‐κB‐independent IL‐8 transactivation in human endothelial cells through induction of AP‐1 , 2002, European journal of immunology.

[22]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[23]  K. Triantafilou,et al.  Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. , 2002, Trends in immunology.

[24]  A. Staubitz,et al.  Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. , 2002, Blood.

[25]  R. Frey,et al.  PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. , 2002, Circulation research.

[26]  D. McCormack,et al.  Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. , 2002, American journal of respiratory and critical care medicine.

[27]  S. Coughlin,et al.  Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[28]  J. Harlan,et al.  Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy , 2002, Critical care medicine.

[29]  W. Aird Endothelial cell dynamics and complexity theory , 2002, Critical care medicine.

[30]  D. Golenbock,et al.  Innate immune recognition of lipopolysaccharide by endothelial cells , 2002, Critical care medicine.

[31]  R. Hotchkiss,et al.  Endothelial cell apoptosis in sepsis , 2002, Critical care medicine.

[32]  A. Schmaier,et al.  Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. , 2002, The American journal of pathology.

[33]  S. Opal,et al.  Antithrombin, heparin, and heparan sulfate , 2002, Critical care medicine.

[34]  G. Zimmerman,et al.  The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis , 2002, Critical care medicine.

[35]  J. Chiche,et al.  The era of genomics: Impact on sepsis clinical trial design , 2002, Critical care medicine.

[36]  T. van der Poll,et al.  Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia1 , 2002, The Journal of Immunology.

[37]  A. Schmaier The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[38]  T. Štefanec The effects of statins on mortality rates among bacteremic patients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. , 2002, Microbes and infection.

[40]  C. Ruppert,et al.  Cell-Specific Nitric Oxide Synthase-Isoenzyme Expression and Regulation in Response to Endotoxin in Intact Rat Lungs , 2002, Laboratory Investigation.

[41]  M. Nishimura,et al.  Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. , 2002, Blood.

[42]  L. Medved,et al.  Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. , 2002, Biochemistry.

[43]  D. Granger,et al.  Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. , 2002, American journal of physiology. Heart and circulatory physiology.

[44]  S. Opal,et al.  Bench-to-bedside review: Toll-like receptors and their role in septic shock , 2002, Critical care.

[45]  D. Bullard,et al.  Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitis. , 2002, Experimental and molecular pathology.

[46]  J. Carcillo,et al.  The Tissue Factor and Plasminogen Activator Inhibitor Type-1 Response in Pediatric Sepsis-induced Multiple Organ Failure , 2002, Thrombosis and Haemostasis.

[47]  R. Codoceo,et al.  Interleukin‐1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis , 2002, Clinical and Experimental Immunology.

[48]  S. Nadel Helping to understand studies examining genetic susceptibility to sepsis , 2002, Clinical and experimental immunology.

[49]  K. Jones,et al.  Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. , 2002, American journal of respiratory and critical care medicine.

[50]  R. Bucala,et al.  Macrophage migration inhibitory factor. , 2002, Critical care medicine.

[51]  K. Zibara,et al.  Acute Hyperglycaemia Induces Changes in the Transcription Levels of 4 Major Genes in Human Endothelial Cells: Macroarrays-based Expression Analysis , 2002, Thrombosis and Haemostasis.

[52]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[53]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[54]  E Peterson,et al.  Early goal-directed therapy in the treatment of severe sepsis and septic shock. , 2018, The New England journal of medicine.

[55]  W. Aird,et al.  Thrombin Stimulation of the Vascular Cell Adhesion Molecule-1 Promoter in Endothelial Cells Is Mediated by Tandem Nuclear Factor-κB and GATA Motifs* , 2001, The Journal of Biological Chemistry.

[56]  M. Levi Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. , 2001, Journal of critical care.

[57]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[58]  M. Carraway,et al.  Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. , 2001, American journal of respiratory and critical care medicine.

[59]  S. Zakynthinos,et al.  Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock , 2001, Intensive Care Medicine.

[60]  S. Liu,et al.  Lipopolysaccharide regulates constitutive and inducible transcription factor activities differentially in vivo in the rat. , 2001, Biochemical and biophysical research communications.

[61]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[62]  G. Bernard,et al.  Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis , 2001, Critical care medicine.

[63]  R. Postier,et al.  Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study , 2001, Critical care medicine.

[64]  W. Aird,et al.  NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. , 2001, American journal of physiology. Cell physiology.

[65]  Ruslan Medzhitov,et al.  Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.

[66]  S. Stavchansky,et al.  Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. , 2001, American journal of physiology. Cell physiology.

[67]  Juan F. García,et al.  Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway , 2001 .

[68]  S. Opal,et al.  High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .

[69]  J. Marshall,et al.  Continuing challenges of sepsis research. , 2001, JAMA.

[70]  A. Malik,et al.  Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[71]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[72]  W. Hancock,et al.  Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[73]  M. Fink Prostaglandins and sepsis: still a fascinating topic despite almost 40 years of research. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[74]  J. Helterbrand,et al.  Low levels of protein C are associated with poor outcome in severe sepsis. , 2001, Chest.

[75]  Jeffrey I. Weitz,et al.  Characterization of a Mouse Model for Thrombomodulin Deficiency , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[76]  L. Platanias,et al.  Protein Kinase C-δ Regulates Thrombin-Induced ICAM-1 Gene Expression in Endothelial Cells via Activation of p38 Mitogen-Activated Protein Kinase , 2001, Molecular and Cellular Biology.

[77]  W. Sessa,et al.  Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[78]  C. Esmon,et al.  Dysfunction of endothelial protein C activation in severe meningococcal sepsis. , 2001, The New England journal of medicine.

[79]  C. Bradley Steroids in sepsis--more effective than activated protein C? , 2001, Intensive & critical care nursing.

[80]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[81]  M. Su,et al.  The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. , 2001, Blood.

[82]  T. Wirth,et al.  Activation of NF-κB via the IκB Kinase Complex Is Both Essential and Sufficient for Proinflammatory Gene Expression in Primary Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[83]  B. Vallet,et al.  Endothelial cell dysfunction and coagulation , 2001, Critical care medicine.

[84]  B. Grinnell,et al.  Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis , 2001, Critical care medicine.

[85]  W. Aird Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis , 2001, Critical care medicine.

[86]  C. Esmon Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation , 2001, Critical care medicine.

[87]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[88]  R. Parker IIb/IIIa or not IIb/IIIa, that is adhesion. , 2001, Critical care medicine.

[89]  R. Bordet,et al.  Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock , 2001, Critical care medicine.

[90]  T. Kodama,et al.  Function of GATA Transcription Factors in Induction of Endothelial Vascular Cell Adhesion Molecule-1 by Tumor Necrosis Factor-&agr; , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[91]  B. Berk,et al.  Fluid shear stress inhibits TNF-α activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[92]  L. Gelbert,et al.  Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.

[93]  G. Guyatt,et al.  New strategies for clinical trials in patients with sepsis and septic shock , 2001, Critical care medicine.

[94]  R. Hofer-Warbinek,et al.  Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. , 2001, Blood.

[95]  T. van der Poll,et al.  IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans1 , 2001, The Journal of Immunology.

[96]  D. Lidington,et al.  Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. , 2001, Journal of applied physiology.

[97]  T. Libermann,et al.  ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene* , 2001, The Journal of Biological Chemistry.

[98]  A. Medvedev,et al.  Bacterial Lipopolysaccharide and IFN-γ Induce Toll-Like Receptor 2 and Toll-Like Receptor 4 Expression in Human Endothelial Cells: Role of NF-κB Activation1 , 2001, The Journal of Immunology.

[99]  M. Quintel,et al.  N-Acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients , 2001, Critical care medicine.

[100]  W. Sibbald,et al.  Endothelial E- and P-selectin expression in iNOS- deficient mice exposed to polymicrobial sepsis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[101]  J. Pugin,et al.  Normal responses to injury prevent systemic inflammation and can be immunosuppressive. , 2001, American journal of respiratory and critical care medicine.

[102]  S. Poole,et al.  Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood , 2001, Critical care medicine.

[103]  N. Christou,et al.  Soluble L-selectin at levels present in septic patients diminishes leukocyte-endothelial cell interactions in mice in vivo: A mechanism for decreased leukocyte delivery to remote sites in sepsis , 2001, Critical care medicine.

[104]  T. van der Poll,et al.  p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo , 2001, The Journal of Immunology.

[105]  D. Perry,et al.  Acquired antithrombin deficiency in sepsis , 2001, British journal of haematology.

[106]  岡本 育 Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture , 2001 .

[107]  A. Durán,et al.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. , 2001, Molecular cell.

[108]  L. Platanias,et al.  Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. , 2001, Molecular and cellular biology.

[109]  T. Wirth,et al.  Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. , 2001, The Journal of biological chemistry.

[110]  A. Medvedev,et al.  Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. , 2001, Journal of immunology.

[111]  I. Singh,et al.  Exposure to febrile temperature modifies endothelial cell response to tumor necrosis factor-alpha. , 2001, Journal of applied physiology.

[112]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[113]  S. Opal,et al.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. , 2001, JAMA.

[114]  A. Malik,et al.  Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice. , 2000, Physiological genomics.

[115]  Nigel Mackman,et al.  Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.

[116]  D. Bernstein,et al.  Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.

[117]  FrançoiseBono,et al.  Factor Xa Activates Endothelial Cells by a Receptor Cascade Between EPR-1 and PAR-2 , 2000 .

[118]  R. Bordet,et al.  Effect of L-arginine on endothelial injury and hemostasis in rabbit endotoxin shock. , 2000, Journal of applied physiology.

[119]  E. Weitzberg,et al.  The endothelin system in septic and endotoxin shock. , 2000, European journal of pharmacology.

[120]  A. Malik,et al.  Protein kinase C-ζ mediates TNF-α-induced ICAM-1 gene transcription in endothelial cells , 2000 .

[121]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[122]  A. Malik,et al.  Mechanisms regulating endothelial cell barrier function. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[123]  A. Goldberg,et al.  Inhibition of ubiquitin-proteasome pathway–mediated IκBα degradation by a naturally occurring antibacterial peptide , 2000 .

[124]  K. Kuwano,et al.  Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. , 2000, The American journal of pathology.

[125]  A. Abidia Endothelial Cell Responses To Hypoxic Stress , 2000, Clinical and experimental pharmacology & physiology.

[126]  Y. Ogura,et al.  Interactions between blood cells and retinal endothelium in endotoxic sepsis. , 2000, Hypertension.

[127]  R. de Caterina,et al.  Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. , 2000, Circulation research.

[128]  J. Marshall Complexity, chaos, and incomprehensibility: parsing the biology of critical illness. , 2000, Critical care medicine.

[129]  A. Seely,et al.  Multiple organ dysfunction syndrome: Exploring the paradigm of complex nonlinear systems , 2000, Critical care medicine.

[130]  T. Kodama,et al.  A novel cell adhesion inhibitor, K-7174, reduces the endothelial VCAM-1 induction by inflammatory cytokines, acting through the regulation of GATA. , 2000, Biochemical and biophysical research communications.

[131]  J. Remacle,et al.  Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. , 2000, Biochimica et biophysica acta.

[132]  P. Neumann,et al.  Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α , 2000 .

[133]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[134]  M. Suematsu,et al.  Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo. , 2000, Circulation research.

[135]  Y. Taniyama,et al.  Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-κB (NF-κB)–Mediated bcl-2 Suppression In Vivo Evidence of the Importance of NF-κB in Endothelial Cell Regulation , 2000 .

[136]  S. Coughlin,et al.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[137]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[138]  W. Kox,et al.  Endothelium function in sepsis , 2000, Inflammation Research.

[139]  D. Granger,et al.  Role of endotoxin in the expression of endothelial selectins after cecal ligation and perforation. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  W. V. Berghe,et al.  Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[141]  J. A. Kruse,et al.  E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. , 2000, JAMA.

[142]  T. Štefanec Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? , 2000, Chest.

[143]  C. Wollheim,et al.  Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[144]  J. Hansen,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Lepirudin blunts endotoxin-induced coagulation activation , 2022 .

[145]  K. Hirata,et al.  Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. , 2000, Circulation.

[146]  S. Nakamura,et al.  Neutrophils express tissue factor in a monkey model of sepsis. , 2000, Surgery.

[147]  A. Zeiher,et al.  Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[148]  山下 智也 Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase , 2000 .

[149]  W. Aird,et al.  The endothelium and thrombosis. , 2000, Seminars in thrombosis and hemostasis.

[150]  A. Goldberg,et al.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. , 2000, The Journal of clinical investigation.

[151]  P. Neumann,et al.  Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[152]  A. Malik,et al.  Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells. , 2000, American journal of physiology. Cell physiology.

[153]  Y. Taniyama,et al.  Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. , 2000, Circulation research.

[154]  M. Pinsky Immune balance in critically ill patients. , 2000, Archivum immunologiae et therapiae experimentalis.

[155]  J. Marshall,et al.  Clinical trials of mediator-directed therapy in sepsis: what have we learned? , 2000, Intensive Care Medicine.

[156]  A. Karsan,et al.  NF-κB Activation Is Required for Human Endothelial Survival during Exposure to Tumor Necrosis Factor-α but Not to Interleukin-1β or Lipopolysaccharide* , 1999, The Journal of Biological Chemistry.

[157]  T. Yokochi,et al.  Complement-Dependent Accumulation and Degradation of Platelets in the Lung and Liver Induced by Injection of Lipopolysaccharides , 1999, Infection and Immunity.

[158]  Z. Brown,et al.  p38 MAPK signalling cascades in inflammatory disease. , 1999, Molecular medicine today.

[159]  N. Prats,et al.  Expression of E-selectin, P-selectin, and intercellular adhesion molecule-1 during experimental murine listeriosis. , 1999, The American journal of pathology.

[160]  S. Coughlin,et al.  How the protease thrombin talks to cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[161]  A. Malik,et al.  Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. , 1999, Circulation.

[162]  N. Tsopanoglou,et al.  On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.

[163]  R. Andriantsitohaina,et al.  Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.

[164]  X. Q. Zhang,et al.  Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. , 1999, Journal of immunology.

[165]  M. Hibberd,et al.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease , 1999, The Lancet.

[166]  J. Dhainaut,et al.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.

[167]  Anand Kumar,et al.  Genetic factors in septic shock. , 1999, JAMA.

[168]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[169]  P. Ward,et al.  Protective effects of C5a blockade in sepsis , 1999, Nature Medicine.

[170]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[171]  C. H. Lin,et al.  Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. , 1999, Circulation.

[172]  S. Deventer,et al.  CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS , 1999 .

[173]  V. Briner,et al.  Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. , 1999, Kidney international.

[174]  M. Gaestel,et al.  MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis , 1999, Nature Cell Biology.

[175]  J. Harlan,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Endothelial Cells Undergoing Apoptosis Become Proadhesive for Nonactivated Platelets , 1999 .

[176]  W. Aird,et al.  Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.

[177]  H. Hamm,et al.  Thrombin Induces Proteinase-activated Receptor-1 Gene Expression in Endothelial Cells via Activation of Gi-linked Ras/Mitogen-activated Protein Kinase Pathway* , 1999, The Journal of Biological Chemistry.

[178]  A. Malik,et al.  Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. , 1999, Journal of immunology.

[179]  J. Carlet From mega to more reasonable doses of corticosteroids: a decade to recreate hope. , 1999, Critical care medicine.

[180]  M. Rothe,et al.  Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.

[181]  A. Karsan,et al.  Mechanisms of Hypoxia-induced Endothelial Cell Death , 1999, The Journal of Biological Chemistry.

[182]  R. Giebler,et al.  Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. , 1999, Critical care medicine.

[183]  G Sherman,et al.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.

[184]  H. Bruining,et al.  Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. , 1999, Circulation.

[185]  M. Gaestel,et al.  Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1, 94-97 , 1999 .

[186]  A. Karsan,et al.  NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide. , 1999, The Journal of biological chemistry.

[187]  T. van der Poll,et al.  Cytokines and anticytokines in the pathogenesis of sepsis. , 1999, Infectious disease clinics of North America.

[188]  M. Gaestel,et al.  MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. , 1999, Nature cell biology.

[189]  A. Sagripanti,et al.  Tissue factor pathway inhibitor. , 1999, Minerva medica.

[190]  S. Goldblum,et al.  Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity and Survival Signaling Events through Caspase Cleavage of Adherens Junction Proteins* , 1998, The Journal of Biological Chemistry.

[191]  M. Schaller,et al.  Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. , 1998, Critical care medicine.

[192]  C. Natanson,et al.  The sirens' songs of confirmatory sepsis trials: selection bias and sampling error. , 1998, Critical care medicine.

[193]  K. Kuwano,et al.  Endothelial Cell Apoptosis in Lipopolysaccharide–Induced Lung Injury in Mice , 1998, International Archives of Allergy and Immunology.

[194]  A. Harken,et al.  THERAPEUTIC IMPLICATIONS OF INTERLEUKIN‐10 IN SURGICAL DISEASE , 1998, Shock.

[195]  S. Gerondakis,et al.  Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. , 1998, The Journal of clinical investigation.

[196]  A. Karsan,et al.  Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. , 1998, Blood.

[197]  P. Carmeliet,et al.  Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. , 1998, The Journal of clinical investigation.

[198]  J. Pouysségur,et al.  Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. , 1998, Molecular biology of the cell.

[199]  A. Karsan,et al.  Lipopolysaccharide Mediates Endothelial Apoptosis by a FADD-dependent Pathway* , 1998, The Journal of Biological Chemistry.

[200]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[201]  H. Rayburn,et al.  A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. , 1998, The Journal of clinical investigation.

[202]  B. Berk,et al.  Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[203]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.

[204]  R. Colman The contact system: A proinflammatory pathway with antithrombotic activity , 1998, Nature Medicine.

[205]  R. Medford,et al.  Role of Activating Protein-1 in the Regulation of the Vascular Cell Adhesion Molecule-1 Gene Expression by Tumor Necrosis Factor-α* , 1998, The Journal of Biological Chemistry.

[206]  R. Hynes,et al.  Platelet-endothelial interactions in inflamed mesenteric venules. , 1998, Blood.

[207]  J. Harlan,et al.  Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα , 1998, The Journal of experimental medicine.

[208]  S. Gullans,et al.  Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1beta-dependent paracrine loop. , 1998, The American journal of pathology.

[209]  B. Schwippert,et al.  Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species , 1998, Diabetologia.

[210]  C. Hack,et al.  Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. , 1998, Journal of immunology.

[211]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.

[212]  B. Alving,et al.  Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy. , 1998, Seminars in thrombosis and hemostasis.

[213]  B. Schwippert,et al.  Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. , 1998, Diabetologia.

[214]  M. Vervloet,et al.  Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic Shock , 1998, Seminars in thrombosis and hemostasis.

[215]  W. Lynn Anti-endotoxin therapeutic options for the treatment of sepsis. , 1998, The Journal of antimicrobial chemotherapy.

[216]  M. Lamy,et al.  Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. , 1998, Intensive care medicine.

[217]  P. Bongrand,et al.  Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). , 1998, Blood.

[218]  M. Fink,et al.  Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. , 1998, The Journal of antimicrobial chemotherapy.

[219]  L. Aiuto,et al.  Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. , 1998, Critical care medicine.

[220]  C. Cordon-Cardo,et al.  Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation , 1997, The Journal of experimental medicine.

[221]  D. Kreutzer,et al.  Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. , 1997, Blood.

[222]  A. Beaudet,et al.  Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. , 1997, The Journal of clinical investigation.

[223]  Jean-PierreCazenave,et al.  Thrombin Receptor-Mediated Increase of Two Matrix Metalloproteinases, MMP-1 and MMP-3, in Human Endothelial Cells , 1997 .

[224]  C. Ferran,et al.  Protective genes expressed in endothelial cells: a regulatory response to injury. , 1997, Immunology today.

[225]  C. Orvain,et al.  Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[226]  D. Männel,et al.  Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.

[227]  S. Cuzzocrea,et al.  Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. , 1997, The Journal of clinical investigation.

[228]  M. Marino,et al.  Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. , 1997, Journal of immunology.

[229]  R. Bone,et al.  Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.

[230]  S. Opal,et al.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.

[231]  C. Natanson,et al.  Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. , 1997, Critical care medicine.

[232]  T. Huizinga,et al.  Genetic influence on cytokine production in meningococcal disease , 1997, The Lancet.

[233]  P. Bongrand,et al.  Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. , 1997, Journal of immunology.

[234]  R. Jordan,et al.  7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli. , 1997, Blood.

[235]  P. Neumann,et al.  Endothelial barrier dysfunction and p42 oxidation induced by TNF-alpha are mediated by nitric oxide. , 1997, The American journal of physiology.

[236]  G. Parry,et al.  Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1 , 1997, European journal of immunology.

[237]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant , 1997 .

[238]  G. Bernard,et al.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.

[239]  E. Holler,et al.  Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. , 1997, Blood.

[240]  A. Haeberli,et al.  Anticoagulant Properties of the Vascular Endothelium , 1997, Thrombosis and Haemostasis.

[241]  M. Lamy,et al.  Sepsis and serum cytokine concentrations. , 1997, Critical care medicine.

[242]  T. Tanaka,et al.  The role of neutrophil elastase in human pulmonary artery endothelial cell injury. , 1997, International archives of allergy and immunology.

[243]  M. Gerritsen,et al.  Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. , 1997, Journal of immunology.

[244]  E. Jaffe,et al.  Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. , 1997, Blood.

[245]  T. van der Poll,et al.  Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. , 1997, Journal of immunology.

[246]  W. Knaus,et al.  Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group. , 1997, JAMA.

[247]  M. Kastan,et al.  Role of p53 in apoptosis. , 1997, Advances in pharmacology.

[248]  C. Haslett,et al.  Modulation of human endothelial thrombomodulin by neutrophils and their release products. , 1997, American journal of respiratory and critical care medicine.

[249]  M. Nehls,et al.  Shear stress inhibits apoptosis of human endothelial cells , 1996, FEBS letters.

[250]  Y. Endo,et al.  Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock , 1996, Infection and immunity.

[251]  D E Griswold,et al.  Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. , 1996, The Journal of pharmacology and experimental therapeutics.

[252]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[253]  R. McCuskey,et al.  The microcirculation during endotoxemia. , 1996, Cardiovascular research.

[254]  P. Tsao,et al.  Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. , 1996, Circulation.

[255]  M. Labow,et al.  Heterogeneity of expression of E- and P-selectins in vivo. , 1996, Circulation research.

[256]  J. Carlet,et al.  INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. , 1996, Critical care medicine.

[257]  I. Adcock,et al.  Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. , 1996, Critical care medicine.

[258]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[259]  S. Opal,et al.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.

[260]  D. Loskutoff,et al.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. , 1996, The Journal of clinical investigation.

[261]  K. Murakami,et al.  Thrombin stimulates production of interleukin‐8 in human umbilical vein endothelial cells , 1996, Immunology.

[262]  R. Colman,et al.  Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. , 1996, Blood.

[263]  A. Manning,et al.  Regional differences in constitutive and induced ICAM-1 expression in vivo. , 1995, The American journal of physiology.

[264]  A. Hoffbrand,et al.  Induction of tissue factor expression in human monocyte/endothelium cocultures , 1995, British journal of haematology.

[265]  O. Smithies,et al.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[266]  W. Waldhäusl,et al.  High-Glucose–Triggered Apoptosis in Cultured Endothelial Cells , 1995, Diabetes.

[267]  E. Connolly,et al.  Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. , 1995, Seminars in cell biology.

[268]  François Gouin,et al.  Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .

[269]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[270]  Craig R. Smith,et al.  Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial , 1995 .

[271]  D. Cook,et al.  Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. , 1995, Critical care medicine.

[272]  R. C. Johnson,et al.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[273]  G. Broze,et al.  Tissue Factor Pathway Inhibitor , 1995, Thrombosis and Haemostasis.

[274]  J. Røttingen,et al.  Binding of Human Factor VIIa to Tissue Factor Induces Cytosolic Ca2+ Signals in J82 Cells, Transfected COS-1 Cells, Madin-Darby Canine Kidney Cells and in Human Endothelial Cells Induced to Synthesize Tissue Factor (*) , 1995, The Journal of Biological Chemistry.

[275]  T. van der Poll,et al.  Complete Inhibition of Endotoxin-Induced Coagulation Activation in Chimpanzees with a Monoclonal Fab Fragment against Factor VII/VIIa , 1995, Thrombosis and Haemostasis.

[276]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[277]  C. Thiemermann,et al.  Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[278]  M. Peterson,et al.  Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein Synthesis , 1994 .

[279]  K. Kaji,et al.  Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. , 1994, Journal of biochemistry.

[280]  S. Lowry,et al.  Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. , 1994, Circulatory shock.

[281]  Craig R. Smith,et al.  Treatment of Septic Shock with Human Monoclonal Antibody HA-1A , 1994, Annals of Internal Medicine.

[282]  A. Mantovani,et al.  Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. , 1994, The American journal of pathology.

[283]  M. Peterson,et al.  Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. , 1994, Experimental cell research.

[284]  J. Dhainaut,et al.  Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. , 1994, Critical care medicine.

[285]  M. Levi,et al.  The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. , 1993, The Journal of clinical investigation.

[286]  P. Ward,et al.  Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1 , 1993 .

[287]  A. Chang,et al.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. , 1993, The Journal of clinical investigation.

[288]  T. Drake,et al.  Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. , 1993, The American journal of pathology.

[289]  X. Ding,et al.  TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. , 1993, The American journal of physiology.

[290]  M. Howard,et al.  Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.

[291]  J. Vincent,et al.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.

[292]  R. Colman,et al.  The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. , 1993, The Journal of clinical investigation.

[293]  P. Ward,et al.  Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. , 1993, The American journal of pathology.

[294]  A. Malik,et al.  Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion , 1992, The Journal of cell biology.

[295]  C. Natanson,et al.  N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin , 1992, The Journal of experimental medicine.

[296]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[297]  A. Malik,et al.  Thrombin-Mediated Increase in Vascular Endothelial Permeability , 1992, Seminars in thrombosis and hemostasis.

[298]  G. Zimmerman,et al.  Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils , 1991, The Journal of cell biology.

[299]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[300]  C. Esmon,et al.  DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. , 1991, Blood.

[301]  F. Taylor,et al.  Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. , 1991, Circulatory shock.

[302]  H. ten Cate,et al.  Factor IX is activated in vivo by the tissue factor mechanism. , 1990, Blood.

[303]  Steven D. Carson,et al.  Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. , 1990, Blood.

[304]  R. Rosenberg Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. , 1989, The American journal of medicine.

[305]  T. Emerson,et al.  Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. , 1989, American Journal of Medicine.

[306]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[307]  B. Meyrick,et al.  Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. , 1989, Journal of applied physiology.

[308]  M. Gimbrone,et al.  Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.

[309]  M. Gerritsen Functional heterogeneity of vascular endothelial cells. , 1987, Biochemical pharmacology.

[310]  A. Chang,et al.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.

[311]  C. Esmon,et al.  Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. , 1987, The Journal of clinical investigation.

[312]  W. Fiers,et al.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[313]  G. Zimmerman,et al.  Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. , 1985, Circulation.

[314]  T. Flægstad,et al.  Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis , 1983, Thrombosis and Haemostasis.

[315]  B. Osterud,et al.  Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. , 1983, Thrombosis and haemostasis.

[316]  H. Wolinsky Circulation Research an Official Journal of the American Heart Association a Proposal Linking Clearance of Circulating Lipoproteins to Tissue Metabolic Activity as a Basis for Understanding Atherogenesis , 2022 .

[317]  F. Taylor,et al.  Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. , 1978, Circulatory shock.

[318]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[319]  L. Díaz-Flores,et al.  [Disseminated intravascular coagulation]. , 1977, Actas dermo-sifiliograficas.